Patients dosed in Phase 1 safety and tolerability study of MDX2003, a novel T-cell engager designed to optimize killing of lymphomas Preclinical studies presented at 2025 American Society of ...

Allogene Therapeutics’ gamble on a never-before-seen trial strategy seems to be paying off, with the biotech’s off-the-shelf cell therapy eradicating residual lymphoma in over half of evaluated pat | ...

Follicular Lymphoma Clinical Trial Space Intensifies with 45+ Companies in Active Development | DelveInsight The follicular lymphoma clinical trial analysis report delivers important insights into ...

Scaling telehealth rehabilitation may reduce travel and facility constraints but must address device/internet availability, ...

Initial results from a high-stakes trial indicate the biotech may have finally found a niche in lymphoma care for a ...

Metabolic tumor volume—a biomarker derived from PET imaging—can more accurately predict progression-free survival for large B ...

After researching lymphomas for more than a decade and beating the illness herself, NYU Langone professor and alum Lisa Roth ...

Tattoos may be a risk factor for malignant lymphoma, according to a Swedish population-based case-control study. Of nearly 12,000 people included in the study, those with tattoos had a higher risk of ...

Could glandular fever lead to brain lymphoma? Specialists Dr Adolfo de la Fuente and Dr Agustín Penedo explain the ...

Burkitt’s lymphoma owes its name to the Irish surgeon Denis P. Burkitt, who in 1958 described 38 Ugandan children with rapidly enlarging facial tumors that were uniformly fatal. 7 He postulated that ...

Academy-Award-winning actress Jane Fonda, 84, recently took to Instagram with some health news: "So, my dear friends, I have something personal I want to share. I've been diagnosed with non-Hodgkin's ...